** Analysts at Jefferies are of the view that Tyro Payments
TYR.AX is focusing on controllables like new partnerships and
product development in spite of a softening macro environment
** Brokerage retains "buy" rating and price target of
A$1.60/shr
** The business support services provider is strategically
focused on growing the health industry segment's Time to Value
(TTV) metric, which Jefferies sees as a long-term positive for
co
** Jefferies suggests turning focus to TYR's evolving
business model with focus on improving profitability, rather
than the near-term weaker macro environment
** Four of 13 analysts rate stock "buy" or higher, eight
rate "hold" and 1 rates "sell" or lower; their median PT is
A$9.38 - LSEG data
** Stock down 28.6% YTD, as of last close
(Reporting by Shivangi Lahiri in Bengaluru)
((Shivangi.Lahiri@thomsonreuters.com;))